About Immuto Scientific
Immuto Scientific is a Healthcare company based in Madison (United States) founded in 2018 by Daniel Benjamin and Faraz Choudhury. Digital drug discovery tools are supplied to researchers. Immuto Scientific has raised $2.3 million across 3 funding rounds from investors including HHS, Wisconsin Investment Partners and WARF. The company has 7 employees. Its chief executive, as recorded, is Daniel Benjamin. Immuto Scientific offers products and services including PLIMB Platform and Epitope Mapping Service. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include Cyrus Biotechnology, Vividion Therapeutics and Seer; 3 of its 3 listed competitors have raised funding.
Company details
Immuto Scientific was established in 2018 in Madison, United States, within the biotechnology sector. Digital platforms for drug discovery are developed and offered to support researchers in pharmaceutical processes. Operations center on computational tools that streamline research workflows. The company is led by co-founders Daniel Benjamin and Faraz Choudhury, who serve as joint CEOs. Focus remains on enabling efficient scientific investigations through technology.
- Headquarters Madison, United States
- Employees 7
- Founders Daniel Benjamin, Faraz Choudhury
- SectorsHealthcare
- Website immutoscientific.com
- Total Equity Funding$2.3M (USD)
in 3 rounds
- Latest Funding Round$2.3M (USD), Seed
Oct 2021
- InvestorsHHS
& 6 more
- Employee Count7
Products & Services of Immuto Scientific
Immuto Scientific offers a comprehensive portfolio of products and services, including PLIMB Platform and Epitope Mapping Service.
Enables high-resolution protein structure and interaction analysis.
Maps epitopes for antibody development and protein interactions.
Funding Insights of Immuto Scientific
Immuto Scientific has successfully raised a total of $2.3M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.3 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.3M
- Total Rounds 3
- Last Round Seed — $2.3M
- Investors Count 7
All 3 funding rounds of Immuto Scientific with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | $2.3M | Seed | – | Wisconsin Investment Partners | |
| Sep 2019 | $2.81M | Grant | – | – | |
| Jun 2018 | Grant | – | – |
7 investors in total: 7 institutional.
Investors in Immuto Scientific
Immuto Scientific has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Wisconsin Investment Partners and WARF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Angel investment and business incubation services are provided. | wisinvpartners.com | Madison, United States | ||
| goldenangelsinvestors.com | ||||
A seed accelerator program is operated to support startups. | madworksaccelerator.org | Madison, United States | ||
Research innovations are supported and commercialized by WARF. | warf.org | Madison, United States | ||
Capital is provided to Wisconsin entrepreneurs for job creation. | brightstarwi.org | Milwaukee, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
| thestartuphub.org |
Investor details for Immuto Scientific
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Immuto Scientific
12 people are tracked at Immuto Scientific (5 in leadership, 3 in board & advisors, 4 in team); the tracked headcount is 7.
| Name | Role | Group |
|---|---|---|
Daniel Benjamin | Co-Founder & CEO | Leadership |
Faraz Choudhury | Co-Founder & CEO | Leadership |
James Dowell | Scientific Director | Leadership |
Hetal Marble | Chief Business Officer | Leadership |
Neal Goodwin | Chief Scientific Officer | Leadership |
Greg Keenan | Board Member | Board & advisors |
Matt Kelly | Board Member | Board & advisors |
John Skilton | Board Member | Board & advisors |
Jon Schmitz | Scientist | Team |
Alexis Lawton | Scientist | Team |
Alex Farahani | Sr. Manager, Discovery Services | Team |
Patric Sadecki | Scientist II | Team |
Complete people profiles for Immuto Scientific
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Immuto Scientific
3 dated milestones of Immuto Scientific across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Immuto Scientific is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $2.3M.
Competitors of Immuto Scientific
Immuto Scientific has 3 listed competitors in our database, 3 of them funded. They include Cyrus Biotechnology, Vividion Therapeutics and Seer.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cyrusbio.com | 2014 | Seattle, United States | $31.99M | 23 | Cloud-based protein-modeling software is developed for drug discovery. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| seer.bio | 2017 | San Francisco, United States | $127.5M | 89 | Proteomics platform developed for early cancer and neurological disease detection. |
Detailed competitors of Immuto Scientific
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Immuto Scientific (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Immuto Scientific
Complete news archive for Immuto Scientific
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Immuto Scientific
Immuto Scientific was founded in 2018.
Immuto Scientific is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Daniel Benjamin is the CEO of Immuto Scientific, as recorded in our data. They have also founded this company.
Immuto Scientific is a funded company, having raised a total of $2.3M across 3 funding rounds to date.
Immuto Scientific has 7 employees.
Immuto Scientific was established in 2018 in Madison, United States, within the biotechnology sector. Digital platforms for drug discovery are developed and offered to support researchers in pharmaceutical processes. Operations center on computational tools that streamline research workflows. The company is led by co-founders Daniel Benjamin and Faraz Choudhury, who serve as joint CEOs. Focus remains on enabling efficient scientific investigations through technology.
Immuto Scientific's top competitors include Vividion Therapeutics, Cyrus Biotechnology and Seer.
Immuto Scientific offers PLIMB Platform and Epitope Mapping Service.
Immuto Scientific has 7 investors. Key investors include HHS, Wisconsin Investment Partners, WARF, thestartuphub.org, and BrightStar Wisconsin Foundation.